Holen Sie sich die Stockscreener-App
3.68
0.27%
0.01
Handel nachbörslich:
3.65
-0.03
-0.82%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.67
Offen:
$3.67
24-Stunden-Volumen:
46,466
Relative Volume:
0.34
Marktkapitalisierung:
$12.36M
Einnahmen:
$36.12M
Nettoeinkommen (Verlust:
$-232.49M
KGV:
-0.207
EPS:
-17.78
Netto-Cashflow:
$-126.87M
1W Leistung:
-1.08%
1M Leistung:
-9.14%
6M Leistung:
-75.88%
1J Leistung:
-93.66%
1-Tages-Spanne:
$3.625
$3.7099
1-Wochen-Bereich:
$3.57
$3.87
52-Wochen-Spanne:
$2.68
$60.60
Bionano Genomics Inc Stock (BNGO) Company Profile
Firmenname
Bionano Genomics Inc
Sektor
Telefon
(858) 888-7600
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Vergleichen Sie BNGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
3.68 | 12.68M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
553.29 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.40 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.17 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.03 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.55 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-12 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-06-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-24 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-04-08 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten
How To Trade (BNGO) - news.stocktradersdaily.com
Bionano Genomics stock rises on Q1 revenue beat - MSN
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Rating of “Hold” by Analysts - Defense World
Bionano Genomics (NASDAQ:BNGO) Stock Rating Upgraded by Wall Street Zen - Defense World
Maxim Group Upgrades Bionano Genomics (NASDAQ:BNGO) to Buy - Defense World
Maxim Group Upgrades Bionano Genomics (BMV:BNGO) - Nasdaq
Maxim Group Upgrades Bionano Genomics (LSE:0A4K) - Nasdaq
Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upg - GuruFocus
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upgrade | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brighten | BNGO Stock News - GuruFocus
Maxim Upgrades Bionano Genomics to Buy From Hold, $8 Price Target - marketscreener.com
Bionano (BNGO) Achieves Milestone with New CPT Code for Genetic - GuruFocus
(BNGO) Long Term Investment Analysis - news.stocktradersdaily.com
Bionano Laboratories Announces a Second Category I CPT Code - GlobeNewswire
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - Yahoo Finance
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2025 Earnings Call Transcript - Insider Monkey
Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more - MSN
Biggest stock movers Thursday: CSCO, FL, BABA, BNGO, and more - MSN
Biggest stock movers Thursday: CSCO, BNGO, and more - MSN
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Q1 2025 Earnings Call Transcript - MarketBeat
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 202 - GuruFocus
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall - Asianet Newsable
Bionano Genomics (BNGO) Refocuses Strategy Amid Revenue Dip - GuruFocus
Bionano outlines $26M–$30M 2025 revenue target as strategic pivot drives higher gross margin - MSN
Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com
Bionano Genomics (BNGO) Sees Strategic Shift Boost in Q1 2025 | - GuruFocus
Bionano Genomics Q1 2025 Earnings: Revenue Beats Estimates at $6 - GuruFocus
Bionano Genomics stock rises on Q1 revenue beat (BNGO:NASDAQ) - Seeking Alpha
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 2025 | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected | BNGO Stock News - GuruFocus
Bionano Genomics Q1 2025 Financial Results - TradingView
A Glimpse of Bionano Genomics's Earnings Potential - Nasdaq
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study - GuruFocus
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study Findings | BNGO Stock News - GuruFocus
Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - The Manila Times
Bionano Laboratories Announces Publication of the Largest - GlobeNewswire
Bionano Genomics (BNGO) Projected to Post Earnings on Wednesday - The AM Reporter
Bionano Genomics (BNGO) to Release Quarterly Earnings on Wednesday - Defense World
When (BNGO) Moves Investors should Listen - news.stocktradersdaily.com
Renaissance Technologies LLC Takes Position in Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - The Manila Times
Geode Capital Management LLC Acquires 114,822 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):